NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines conference, Brussels, November 21, 2018
This event is organized by Medicines for Europe about ” an innovative approach for patients’ future”.
Breaking News
New trial protocol guidance: Updated in SPIRIT but falling short on adherence
In the early stages of drug development, as the promise surrounding a new therapy builds, there is a palpable sense of the stakes being raised. And when encouraging findings lead to progress on the clinical trial pathway, those stakes are
Oksana Pidmogylna
June 19, 2025
